{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:28Z","timestamp":1787243008822,"version":"build-2736575974"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/zwam1063","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T03:00:12Z","timestamp":1735614012000},"page":"5851-5862","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective analysis of clinical and molecular characteristics as prognostic factors in adult T-cell lymphoblastic lymphoma"],"prefix":"10.62347","volume":"14","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","unstructured":"Pagliaro L, Chen SJ, Herranz D, Mecucci C, Harrison CJ, Mullighan CG, Zhang M, Chen Z, Boissel N, Winter SS and Roti G. Acute lymphoblastic leukaemia. Nat Rev Dis Primers 2024; 10: 41.","journal-title":"Nat Rev Dis Primers"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","unstructured":"Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M, DeSantes K, Kelly K, Kitko C, Lacayo N, Larrier N, Maese L, Mahadeo K, Nanda R, Nardi V, Rodriguez V, Rossoff J, Schuettpelz L, Silverman L, Sun J, Sun W, Teachey D, Wong V, Yanik G, Johnson-Chilla A and Ogba N. Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2020; 18: 81-112.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kroeze E, Loeffen JLC, Poort VM and Meijerink JPP. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? Blood Adv 2020; 4: 3466-3473.","DOI":"10.1182\/bloodadvances.2020001822"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2021.03.01","article-title":"Chinese society of clinical oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)","volume":"33","author":"Zhu","year":"2021","unstructured":"Zhu J and Ma J; Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology. Chinese society of clinical oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version). Chin J Cancer Res 2021; 33: 289-301.","journal-title":"Chin J Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.32604\/biocell.2023.043084","article-title":"Effects of platelets on characteristics of lymphocytes cultured in vitro and optimization of adoptive immunotherapy","volume":"47","author":"Chen","year":"2023","unstructured":"Chen C, Leng X, Zhang Y, Hu J, Wei D, Wang P and Wang X. Effects of platelets on characteristics of lymphocytes cultured in vitro and optimization of adoptive immunotherapy. Biocell 2023; 47: 2661-2669.","journal-title":"Biocell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.32604\/biocell.2024.048946","article-title":"Identification of prognostic molecular subtypes and model based on CD8+ T cells for lung adenocarcinoma","volume":"48","author":"Cao","year":"2024","unstructured":"Cao H, Xue Y, Wang F, Li G, Zhen Y and Guo J. Identification of prognostic molecular subtypes and model based on CD8+ T cells for lung adenocarcinoma. Biocell 2024; 48: 473-490.","journal-title":"Biocell"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","article-title":"Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine","volume":"96","author":"Morita","year":"2021","unstructured":"Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K, Garcia-Manero G, Konoplev S, Ravandi F, Khoury JD and Jabbour E. Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol 2021; 96: 589-598.","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01168-x","article-title":"Lymphoblastic lymphoma: a concise review","volume":"24","author":"Intermesoli","year":"2022","unstructured":"Intermesoli T, Weber A, Leoncin M, Frison L, Skert C and Bassan R. Lymphoblastic lymphoma: a concise review. Curr Oncol Rep 2022; 24: 1-12.","journal-title":"Curr Oncol Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21147\/j.issn.1000-9604.2022.02.03","article-title":"Genomic landscape of T-cell lymphoblastic lymphoma","volume":"34","author":"Li","year":"2022","unstructured":"Li Z, Song Y, Zhang M, Wei Y and Ruan H. Genomic landscape of T-cell lymphoblastic lymphoma. Chin J Cancer Res 2022; 34: 83-94.","journal-title":"Chin J Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1158\/1078-0432.CCR-19-4207","article-title":"A CpG methylation classifier to predict relapse in adults with T-cell lymphoblastic lymphoma","volume":"26","author":"Tian","year":"2020","unstructured":"Tian XP, Su N, Wang L, Huang WJ, Liu YH, Zhang X, Huang HQ, Lin TY, Ma SY, Rao HL, Li M, Liu F, Zhang F, Zhong LY, Liang L, Lan XL, Li J, Liao B, Li ZH, Tang QL, Liang Q, Shao CK, Zhai QL, Cheng RF, Sun Q, Ru K, Gu X, Lin XN, Yi K, Shuang YR, Chen XD, Dong W, Sun C, Sang W, Liu H, Zhu ZG, Rao J, Guo QN, Zhou Y, Meng XL, Zhu Y, Hu CL, Jiang YR, Zhang Y, Gao HY, He WJ, Xia ZJ, Pan XY, Hai L, Li GW, Song LY, Kang TB, Xie D and Cai QQ. A CpG methylation classifier to predict relapse in adults with T-cell lymphoblastic lymphoma. Clin Cancer Res 2020; 26: 3760-3770.","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Young KH. Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine? Leukemia 2020; 34: 1213-1214.","DOI":"10.1038\/s41375-019-0608-4"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","article-title":"Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence","volume":"121","author":"Bonn","year":"2013","unstructured":"Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F, Wrobel G, Attarbaschi A, Escherich G, Klapper W, Reiter A and Burkhardt B. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013; 121: 3153-3160.","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.14017","article-title":"Current status and future directions of T-lymphoblastic lymphoma in children and adolescents","volume":"173","author":"Burkhardt","year":"2016","unstructured":"Burkhardt B, Mueller S, Khanam T and Perkins SL. Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. Br J Haematol 2016; 173: 545-559.","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study","volume":"34","author":"Lepretre","year":"2016","unstructured":"Lepretre S, Touzart A, Vermeulin T, Picquenot JM, Tanguy-Schmidt A, Salles G, Lamy T, Bene MC, Raffoux E, Huguet F, Chevallier P, Bologna S, Bouabdallah R, Benichou J, Briere J, Moreau A, Tallon-Simon V, Seris S, Graux C, Asnafi V, Ifrah N, Macintyre E and Dombret H. Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study. J Clin Oncol 2016; 34: 572-580.","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","unstructured":"Kantarjian H, Stein A, Gokbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Foa R, Bassan R, Arslan O, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Bruggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z and Topp MS. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med 2017; 376: 836-847.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/PPO.0b013e31826b1232","article-title":"Adult lymphoblastic lymphoma","volume":"18","author":"Portell","year":"2012","unstructured":"Portell CA and Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J 2012; 18: 432-438.","journal-title":"Cancer J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lheritier V, Macintyre E, Bene MC, Ifrah N and Dombret H. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 2009; 27: 911-918.","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1182\/blood.V122.21.839.839","article-title":"Significant improvement of outcome in adolescents and young adults (AYAs) aged 15-35 years with acute lymphoblastic leukemia (ALL) with a pediatric derived adult all protocol; results of 1529 AYAs in 2 consecutive trials of the german multicenter study group for adult ALL (GMALL)","volume":"122","author":"G&#xF6","year":"2013","unstructured":"Gökbuget N, Beck J, Brandt K, Brüggemann M, Burmeister T, Diedrich H, Faul C, Hüttmann A, Kondakci M and Kraemer D. Significant improvement of outcome in adolescents and young adults (AYAs) aged 15-35 years with acute lymphoblastic leukemia (ALL) with a pediatric derived adult all protocol; results of 1529 AYAs in 2 consecutive trials of the german multicenter study group for adult ALL (GMALL). Blood 2013; 122: 839.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/bjh.19481","article-title":"Allogeneic haematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicentre analysis in China","volume":"204","author":"Huo","year":"2024","unstructured":"Huo W, Gao L, Song K, Huang J, Wang N, Cao L, Liu Y, Wang F, Li C, Zhu X, Wu X, Cao Y, Mo X and Hu X. Allogeneic haematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicentre analysis in China. Br J Haematol 2024; 204: 2390-2399.","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.18632\/aging.204008","article-title":"Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen","volume":"14","author":"Yu","year":"2022","unstructured":"Yu H, Mi L, Qi F, Wang X, Ye Y, Li M, Wang D, Ding N, Wang X, Song Y, Zhu J and Xie Y. Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen. Aging (Albany NY) 2022; 14: 3203-3215.","journal-title":"Aging (Albany NY)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/CM9.0000000000002235","article-title":"Current status and prospects of hematopoietic stem cell transplantation in China","volume":"135","author":"Wang","year":"2022","unstructured":"Wang X, Huang R, Zhang X and Zhang X. Current status and prospects of hematopoietic stem cell transplantation in China. Chin Med J (Engl) 2022; 135: 1394-1403.","journal-title":"Chin Med J (Engl)"},{"key":"ref21","unstructured":"Yuan Y, Zang L, Yue Z, Zhang Y and Wang X. Clinical features and prognosis of 74 cases of lymphoblastic lymphoma. Cancer Research on Prevention and Treatment 2018; 45: 154-159."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.2021014498","article-title":"Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL\/LBL: first-in-human phase 1 clinical trial","volume":"140","author":"Lu","year":"2022","unstructured":"Lu P, Liu Y, Yang J, Zhang X, Yang X, Wang H, Wang L, Wang Q, Jin D, Li J and Huang X. Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL\/LBL: first-in-human phase 1 clinical trial. Blood 2022; 140: 321-334.","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/ajh.27094","article-title":"Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy","volume":"98","author":"Zhang","year":"2023","unstructured":"Zhang X, Yang J, Li J, Qiu L, Zhang J, Lu Y, Zhao YL, Jin D, Li J and Lu P. Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy. Am J Hematol 2023; 98: 1898-1908.","journal-title":"Am J Hematol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-21-4097","article-title":"Autologous nanobody-derived fratricide-resistant CD7-CAR T-cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia\/lymphoma","volume":"28","author":"Zhang","year":"2022","unstructured":"Zhang M, Chen D, Fu X, Meng H, Nan F, Sun Z, Yu H, Zhang L, Li L, Li X, Wang X, Wang M, You F, Li Z, Chang Y, Zhou Z, Yan J, Li J, Wu X, Wang Y, Wang Y, Xiang S, Chen Y, Pan G, Xu H, Zhang B and Yang L. Autologous nanobody-derived fratricide-resistant CD7-CAR T-cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia\/lymphoma. Clin Cancer Res 2022; 28: 2830-2843.","journal-title":"Clin Cancer Res"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/12\/ajcr0160872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:51:40Z","timestamp":1766022700000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/12\/ajcr0160872.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/zwam1063","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}